TEOSYAL RHA® 1 for the Correction of Moderate to Severe Tissue Volume Deficiency in the Infraorbital Region in Chinese Adults
Clinical trial NCT06749587 · RECRUITING
Trial details
- NCT number
- NCT06749587
- Sponsor
- Teoxane SA
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-12
- Primary completion
- 2025-03-12
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.